|
|
Post by rockstarrick on Aug 28, 2014 19:08:12 GMT -5
|
|
|
|
Post by coco on Aug 28, 2014 20:16:34 GMT -5
Excellent article. I read this article over and over again when I get nervous. It reminds me just how good of a product that we have here. We can't let the shorts get to us, even though it is hard at times. Coco  |
|
|
|
Post by rockstarrick on Aug 28, 2014 21:17:21 GMT -5
Thanks coco, I agree, this a very good article, it really tells the whole story. The shorts are living on a prayer, the fate of Afrezza is in the hands of the Diabetic population of the world now, we will win because they will win. That's much more important to than any financial gain, if Afrezza works, and we know it does, the diabetics will switch, they will experience the benefits of Afrezza, the sales will go through the roof, and the shareholders will benefit for supporting a good cause. How can it get any better than that. Have a great evening RSR
|
|
|
|
Post by kc on Aug 28, 2014 21:57:53 GMT -5
Thanks for posting this article. It's a great reminder as to why we made this investment originally and the benefit to all MannKind.
Keep the faith. We will see a new Sunrise soon.
Marcelo Zinn's piece is worth sharing. Best take away is this comment.
Using Einstein’s inversion maxim: if inhalable insulin was invented first and another pharmaceutical company developed an insulin treatment whose only major difference was that it was injectable, how many people would switch?
We believe the answer could not be any clearer: absolutely none.
|
|
|
|
Post by mnholdem on Aug 29, 2014 3:42:32 GMT -5
I emailed them a few weeks ago requesting an update and reprint. Now that Zinn knows it's a 35/65 with upfront by Sanofi the various scenarios near the end of the piece can be dialed in to one. No reply yet, but I hope it's being considered.
|
|
|
|
Post by rockstarrick on Aug 29, 2014 8:01:26 GMT -5
Mnholdem, you have been on a roll, great research, all quality work. Every time you post, I learn something. RSR
|
|
|
|
Post by zieg on Aug 29, 2014 9:43:08 GMT -5
I emailed them a few weeks ago requesting an update and reprint. Now that Zinn knows it's a 35/65 with upfront by Sanofi the various scenarios near the end of the piece can be dialed in to one. No reply yet, but I hope it's being considered. I just reached out to him (Zinn) as well as I see he too lives here in Miami (thanks KC). If I connect w/him, I will keep all posted. |
|
